{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["hepatocellular carcinoma", "liver cancer", "metastasis", "natural compounds", "phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34830907", "DateRevised": {"Year": "2021", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["5753", "10.3390/cancers13225753"], "Journal": {"ISSN": "2072-6694", "JournalIssue": {"Volume": "13", "Issue": "22", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "17"}}, "Title": "Cancers", "ISOAbbreviation": "Cancers (Basel)"}, "ArticleTitle": "Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma.", "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC) is the most abundant form of liver cancer. It accounts for 75-85% of liver cancer cases and, though it ranks globally as the sixth most common cancer, it ranks second in cancer-related mortality. Deaths from HCC are usually due to metastatic spread of the cancer. Unfortunately, there are many challenges and limitations with the latest HCC therapies and medications, making it difficult for patients to receive life-prolonging care. As there is clearly a high demand for alternative therapy options for HCC, it is prudent to turn to plants for the solution, as their phytochemicals have long been used and revered for their many medicinal purposes. This review explores the promising phytochemical compounds identified from pre-clinical and clinical trials being used either independently or in conjunction with already existing cancer therapy treatments. The phytochemicals discussed in this review were classified into several categories: lipids, polyphenols, alkaloids, polysaccharides, whole extracts, and phytochemical combinations. Almost 80% of the compounds failed to progress into clinical studies due to lack of information regarding the toxicity to normal cells and bioavailability. Although large obstacles remain, phytochemicals can be used either as an alternative or integrative therapy in conjunction with existing HCC chemotherapies. In conclusion, phytochemicals have great potential as treatment options for hepatocellular carcinoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Emphasis in Cancer Research, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA."}], "LastName": "Rodriguez", "ForeName": "Sheryl", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA."}], "LastName": "Skeet", "ForeName": "Kristy", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Emphasis in Cancer Research, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA."}], "LastName": "Mehmetoglu-Gurbuz", "ForeName": "Tugba", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA."}], "LastName": "Goldfarb", "ForeName": "Madeline", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA."}], "LastName": "Karri", "ForeName": "Shri", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA."}], "LastName": "Rocha", "ForeName": "Jackelyn", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA."}], "LastName": "Shahinian", "ForeName": "Mark", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA."}], "LastName": "Yazadi", "ForeName": "Abdallah", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Emphasis in Cancer Research, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA."}], "LastName": "Poudel", "ForeName": "Seeta", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Emphasis in Cancer Research, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA."}, {"Identifier": [], "Affiliation": "Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA."}], "LastName": "Subramani", "ForeName": "Ramadevi", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cancers (Basel)", "NlmUniqueID": "101526829", "ISSNLinking": "2072-6694"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Sagnelli E., Macera M., Russo A., Coppola N., Sagnelli C. Epidemiological and etiological variations in hepatocellular carcinoma. Infection. 2020;48:7\u201317. doi: 10.1007/s15010-019-01345-y.", "ArticleIdList": ["10.1007/s15010-019-01345-y", "31347138"]}, {"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Sarveazad A., Agah S., Babahajian A., Amini N., Bahardoust M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J. Res. Med. Sci. 2019;24:86. doi: 10.4103/jrms.JRMS_1017_18.", "ArticleIdList": ["10.4103/jrms.JRMS_1017_18", "PMC6856560", "31741658"]}, {"Citation": "Sun W., Fu S., Wu S., Tu R. Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma. Biomed Res. Int. 2020;2020:4501454. doi: 10.1155/2020/4501454.", "ArticleIdList": ["10.1155/2020/4501454", "PMC7719499", "33313314"]}, {"Citation": "Keating G.M. Sorafenib: A Review in Hepatocellular Carcinoma. Target Oncol. 2017;12:243\u2013253. doi: 10.1007/s11523-017-0484-7.", "ArticleIdList": ["10.1007/s11523-017-0484-7", "28299600"]}, {"Citation": "de Martel C., Maucort-Boulch D., Plummer M., Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62:1190\u20131200. doi: 10.1002/hep.27969.", "ArticleIdList": ["10.1002/hep.27969", "PMC5019261", "26146815"]}, {"Citation": "Chen D.S. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Princess Takamatsu Symp. 1995;25:27\u201332.", "ArticleIdList": ["8875606"]}, {"Citation": "Zhang D.Y., Friedman S.L. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 2012;56:769\u2013775. doi: 10.1002/hep.25670.", "ArticleIdList": ["10.1002/hep.25670", "PMC4087159", "22378017"]}, {"Citation": "Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis. 2010;42((Suppl. 3)):S206\u2013S214. doi: 10.1016/S1590-8658(10)60507-5.", "ArticleIdList": ["10.1016/S1590-8658(10)60507-5", "PMC3392755", "20547305"]}, {"Citation": "Gentile D., Donadon M., Lleo A., Aghemo A., Roncalli M., di Tommaso L., Torzilli G. Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review. Liver Cancer. 2020;9:15\u201327. doi: 10.1159/000503719.", "ArticleIdList": ["10.1159/000503719", "PMC7024854", "32071906"]}, {"Citation": "Wong T.C., Lo C.M. Resection strategies for hepatocellular carcinoma. Semin Liver Dis. 2013;33:273\u2013281. doi: 10.1055/s-0033-1351782.", "ArticleIdList": ["10.1055/s-0033-1351782", "23943107"]}, {"Citation": "Lau W.Y., Leung T.W., Lai B.S., Liew C.T., Ho S.K., Yu S.C., Tang A.M. Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma. Ann. Surg. 2001;233:236\u2013241. doi: 10.1097/00000658-200102000-00013.", "ArticleIdList": ["10.1097/00000658-200102000-00013", "PMC1421206", "11176130"]}, {"Citation": "Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996;334:693\u2013699. doi: 10.1056/NEJM199603143341104.", "ArticleIdList": ["10.1056/NEJM199603143341104", "8594428"]}, {"Citation": "Spallanzani A., Orsi G., Andrikou K., Gelsomino F., Rimini M., Riggi L., Cascinu S. Lenvatinib as a therapy for unresectable hepatocellular carcinoma. Expert Rev. Anticancer Ther. 2018;18:1069\u20131076. doi: 10.1080/14737140.2018.1524297.", "ArticleIdList": ["10.1080/14737140.2018.1524297", "30220234"]}, {"Citation": "Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., de Oliveira A.C., Santoro A., Raoul J.L., Forner A., et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 2008;359:378\u2013390. doi: 10.1056/NEJMoa0708857.", "ArticleIdList": ["10.1056/NEJMoa0708857", "18650514"]}, {"Citation": "Rimassa L., Pressiani T., Merle P. Systemic Treatment Options in Hepatocellular Carcinoma. Liver Cancer. 2019;8:427\u2013446. doi: 10.1159/000499765.", "ArticleIdList": ["10.1159/000499765", "PMC6883446", "31799201"]}, {"Citation": "Zheng A., Chevalier N., Calderoni M., Dubuis G., Dormond O., Ziros P.G., Sykiotis G.P., Widmann C. CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma. Oncotarget. 2019;10:7058\u20137070. doi: 10.18632/oncotarget.27361.", "ArticleIdList": ["10.18632/oncotarget.27361", "PMC6925031", "31903165"]}, {"Citation": "Ao J., Chiba T., Shibata S., Kurosugi A., Qiang N., Ma Y., Kan M., Iwanaga T., Sakuma T., Kanzaki H., et al. Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2021;549:171\u2013178. doi: 10.1016/j.bbrc.2021.02.097.", "ArticleIdList": ["10.1016/j.bbrc.2021.02.097", "33676186"]}, {"Citation": "Tang W., Chen Z., Zhang W., Cheng Y., Zhang B., Wu F., Wang Q., Wang S., Rong D., Reiter F.P., et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects. Signal. Transduct. Target. Ther. 2020;5:87. doi: 10.1038/s41392-020-0187-x.", "ArticleIdList": ["10.1038/s41392-020-0187-x", "PMC7292831", "32532960"]}, {"Citation": "Raoul J.L., Gilabert M., Oziel-Ta\u00efeb S., Giovannini M. Palliative treatment for hepatocellular carcinoma. Rev. Prat. 2013;63:233\u2013236.", "ArticleIdList": ["23513793"]}, {"Citation": "Habib A., Desai K., Hickey R., Thornburg B., Lewandowski R., Salem R. Locoregional therapy of hepatocellular carcinoma. Clin. Liver Dis. 2015;19:401\u2013420. doi: 10.1016/j.cld.2015.01.008.", "ArticleIdList": ["10.1016/j.cld.2015.01.008", "25921670"]}, {"Citation": "Sangro B., I\u00f1arrairaegui M., Bilbao J.I. Radioembolization for hepatocellular carcinoma. J. Hepatol. 2012;56:464\u2013473. doi: 10.1016/j.jhep.2011.07.012.", "ArticleIdList": ["10.1016/j.jhep.2011.07.012", "21816126"]}, {"Citation": "Helgason C.M. Commentary on the significance for modern neurology of the 17th century B.C. Surgical Papyrus. Can. J. Neurol. Sci. 1987;14:560\u2013563.", "ArticleIdList": ["3319119"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043. doi: 10.1021/cr900019j.", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Zhou D.D., Luo M., Shang A., Mao Q.Q., Li B.Y., Gan R.Y., Li H.B. Antioxidant Food Components for the Prevention and Treatment of Cardiovascular Diseases: Effects, Mechanisms, and Clinical Studies. Oxid. Med. Cell Longev. 2021;2021:6627355. doi: 10.1155/2021/6627355.", "ArticleIdList": ["10.1155/2021/6627355", "PMC7864729", "33574978"]}, {"Citation": "Graf B.L., Raskin I., Cefalu W.T., Ribnicky D.M. Plant-derived therapeutics for the treatment of metabolic syndrome. Curr. Opin. Investig. Drugs. 2010;11:1107\u20131115.", "ArticleIdList": ["PMC3755736", "20872313"]}, {"Citation": "Sharifi-Rad M., Lankatillake C., Dias D.A., Docea A.O., Mahomoodally M.F., Lobine D., Chazot P.L., Kurt B., Tumer T.B., Moreira A.C., et al. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics. J. Clin. Med. 2020;9:1061. doi: 10.3390/jcm9041061.", "ArticleIdList": ["10.3390/jcm9041061", "PMC7231062", "32276438"]}, {"Citation": "Zhou T., Ye L., Bai Y., Sun A., Cox B., Liu D., Li Y., Liotta D., Snyder J.P., Fu H., et al. Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: A novel curcumin analog. PLoS ONE. 2014;9:e107876. doi: 10.1371/journal.pone.0107876.", "ArticleIdList": ["10.1371/journal.pone.0107876", "PMC4182433", "25268357"]}, {"Citation": "Zhao Z., Malhotra A., Seng W.Y. Curcumin Modulates Hepatocellular Carcinoma by Reducing UNC119 Expression. J. Environ. Pathol. Toxicol. Oncol. 2019;38:195\u2013203. doi: 10.1615/JEnvironPatholToxicolOncol.2019029549.", "ArticleIdList": ["10.1615/JEnvironPatholToxicolOncol.2019029549", "31679307"]}, {"Citation": "Zheng M., Chen R., Zhong H., Lin Q., Wang X., Zhao Z., Xie L. Side-effects of resveratrol in HepG2 cells: Reduced pten and increased bcl-xl mRNA expression. Mol. Med. Rep. 2012;6:1367\u20131370. doi: 10.3892/mmr.2012.1077.", "ArticleIdList": ["10.3892/mmr.2012.1077", "22971900"]}, {"Citation": "Zhang Q., Huang H., Zheng F., Liu H., Qiu F., Chen Y., Liang C.L., Dai Z. Resveratrol exerts antitumor effects by downregulating CD8. Oncoimmunology. 2020;9:1829346. doi: 10.1080/2162402X.2020.1829346.", "ArticleIdList": ["10.1080/2162402X.2020.1829346", "PMC7588216", "33150044"]}, {"Citation": "Wu L., Li J., Liu T., Li S., Feng J., Yu Q., Zhang J., Chen J., Zhou Y., Ji J., et al. Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway. Cancer Med. 2019;8:4806\u20134820. doi: 10.1002/cam4.2388.", "ArticleIdList": ["10.1002/cam4.2388", "PMC6712453", "31273958"]}, {"Citation": "Zhang S., Yang Y., Liang Z., Duan W., Yang J., Yan J., Wang N., Feng W., Ding M., Nie Y., et al. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells. PLoS ONE. 2013;8:e83699. doi: 10.1371/journal.pone.0083699.", "ArticleIdList": ["10.1371/journal.pone.0083699", "PMC3873967", "24386256"]}, {"Citation": "Rawat D., Shrivastava S., Naik R.A., Chhonker S.K., Mehrotra A., Koiri R.K. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma. Anticancer Agents Med. Chem. 2018;18:1838\u20131859. doi: 10.2174/1871520618666180604085612.", "ArticleIdList": ["10.2174/1871520618666180604085612", "29866017"]}, {"Citation": "Watanabe S., Kitade Y., Masaki T., Nishioka M., Satoh K., Nishino H. Effects of lycopene and Sho-saiko-to on hepatocarcinogenesis in a rat model of spontaneous liver cancer. Nutr. Cancer. 2001;39:96\u2013101. doi: 10.1207/S15327914nc391_13.", "ArticleIdList": ["10.1207/S15327914nc391_13", "11588908"]}, {"Citation": "Thomas C.E., Luu H.N., Wang R., Adams-Haduch J., Jin A., Koh W.P., Yuan J.M. Association between Dietary Tomato Intake and the Risk of Hepatocellular Carcinoma: The Singapore Chinese Health Study. Cancer Epidemiol. Biomark. Prev. 2020;29:1430\u20131435. doi: 10.1158/1055-9965.EPI-20-0051.", "ArticleIdList": ["10.1158/1055-9965.EPI-20-0051", "PMC7685773", "32284341"]}, {"Citation": "Xia H., Liu C., Li C.C., Fu M., Takahashi S., Hu K.Q., Aizawa K., Hiroyuki S., Wu G., Zhao L., et al. Dietary Tomato Powder Inhibits High-Fat Diet-Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage Enzymes. Cancer Prev. Res. 2018;11:797\u2013810. doi: 10.1158/1940-6207.CAPR-18-0188.", "ArticleIdList": ["10.1158/1940-6207.CAPR-18-0188", "30446518"]}, {"Citation": "Zhou R.S., Wang X.W., Sun Q.F., Ye Z.J., Liu J.W., Zhou D.H., Tang Y. Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis. Biomed Res. Int. 2019;2019:3065818. doi: 10.1155/2019/3065818.", "ArticleIdList": ["10.1155/2019/3065818", "PMC6545785", "31236404"]}, {"Citation": "Subramaniam A., Shanmugam M.K., Ong T.H., Li F., Perumal E., Chen L., Vali S., Abbasi T., Kapoor S., Ahn K.S., et al. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. Br. J. Pharmacol. 2013;170:807\u2013821. doi: 10.1111/bph.12302.", "ArticleIdList": ["10.1111/bph.12302", "PMC3799595", "23848338"]}, {"Citation": "Wang Z., Gu C., Wang X., Lang Y., Wu Y., Wu X., Zhu X., Wang K., Yang H. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma. Med. Oncol. 2019;36:97. doi: 10.1007/s12032-019-1323-8.", "ArticleIdList": ["10.1007/s12032-019-1323-8", "31664534"]}, {"Citation": "Saraswati S., Alhaider A., Abdelgadir A.M., Tanwer P., Korashy H.M. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma. Cell Commun. Signal. 2019;17:127. doi: 10.1186/s12964-019-0430-7.", "ArticleIdList": ["10.1186/s12964-019-0430-7", "PMC6794763", "31619257"]}, {"Citation": "Luo H., Wang Y.J., Chen J., Liu J.Q. Study on the effect of phloretin on inhibiting malignant pheotype of BEL-7402 cells. Zhong Yao Cai. 2008;31:1019\u20131021.", "ArticleIdList": ["18973020"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Karimi A., Majlesi M., Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J. Nephropharmacol. 2015;4:27\u201330.", "ArticleIdList": ["PMC5297475", "28197471"]}, {"Citation": "Mondal A., Guria T., Maity T.K., Bishayee A. A Novel Tetraenoic Fatty Acid Isolated from Amaranthus spinosus Inhibits Proliferation and Induces Apoptosis of Human Liver Cancer Cells. Int. J. Mol. Sci. 2016;17:1604. doi: 10.3390/ijms17101604.", "ArticleIdList": ["10.3390/ijms17101604", "PMC5085637", "27669220"]}, {"Citation": "Dasgupta A., Dey D., Ghosh D., Lai T.K., Bhuvanesh N., Dolui S., Velayutham R., Acharya K. Astrakurkurone, a sesquiterpenoid from wild edible mushroom, targets liver cancer cells by modulating Bcl-2 family proteins. IUBMB Life. 2019;71:992\u20131002. doi: 10.1002/iub.2047.", "ArticleIdList": ["10.1002/iub.2047", "30977280"]}, {"Citation": "Kim D.K., Baek J.H., Kang C.M., Yoo M.A., Sung J.W., Chung H.Y., Kim N.D., Choi Y.H., Lee S.H., Kim K.W. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int. J. Cancer. 2000;87:629\u2013636. doi: 10.1002/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P.", "ArticleIdList": ["10.1002/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P", "10925354"]}, {"Citation": "Kim G.H., Kan S.Y., Kang H., Lee S., Ko H.M., Kim J.H., Lim J.H. Ursolic Acid Suppresses Cholesterol Biosynthesis and Exerts Anti-Cancer Effects in Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2019;20:4767. doi: 10.3390/ijms20194767.", "ArticleIdList": ["10.3390/ijms20194767", "PMC6802365", "31561416"]}, {"Citation": "Shyu M.H., Kao T.C., Yen G.C. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J. Agric. Food Chem. 2010;58:6110\u20136118. doi: 10.1021/jf100574j.", "ArticleIdList": ["10.1021/jf100574j", "20415421"]}, {"Citation": "Yang L., Zhang X.Y., Li K., Li A.P., Yang W.D., Yang R., Wang P., Zhao Z.H., Cui F., Qin Y., et al. Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway. Cell Death Dis. 2019;10:630. doi: 10.1038/s41419-019-1733-8.", "ArticleIdList": ["10.1038/s41419-019-1733-8", "PMC6702205", "31431619"]}, {"Citation": "Lou L., Ye W., Chen Y., Wu S., Jin L., He J., Tao X., Zhu J., Chen X., Deng A., et al. Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine. 2012;19:603\u2013608. doi: 10.1016/j.phymed.2012.01.003.", "ArticleIdList": ["10.1016/j.phymed.2012.01.003", "22349030"]}, {"Citation": "Durmaz I., Guven E.B., Ersahin T., Ozturk M., Calis I., Cetin-Atalay R. Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status. Phytomedicine. 2016;23:42\u201351. doi: 10.1016/j.phymed.2015.11.012.", "ArticleIdList": ["10.1016/j.phymed.2015.11.012", "26902406"]}, {"Citation": "Ko H., Huh G., Jung S.H., Kwon H., Jeon Y., Park Y.N., Kim Y.J. Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma. Food Chem. Toxicol. 2020;142:111475. doi: 10.1016/j.fct.2020.111475.", "ArticleIdList": ["10.1016/j.fct.2020.111475", "32522589"]}, {"Citation": "Liao W., Fan L., Zheng Z., Liu H., Deng H., Li M., Liu F., Yang A. Ziyuglycoside II exerts antiproliferative and antimetastasis effects on hepatocellular carcinoma cells. Anticancer Drugs. 2020;31:819\u2013827. doi: 10.1097/CAD.0000000000000918.", "ArticleIdList": ["10.1097/CAD.0000000000000918", "32097137"]}, {"Citation": "Wang T., Dou Y., Lin G., Li Q., Nie J., Chen B., Xie J., Su Z., Zeng H., Chen J., et al. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role. Biomed Pharm. 2021;134:111122. doi: 10.1016/j.biopha.2020.111122.", "ArticleIdList": ["10.1016/j.biopha.2020.111122", "33341052"]}, {"Citation": "Jung K.H., Rumman M., Yan H., Cheon M.J., Choi J.G., Jin X., Park S., Oh M.S., Hong S.S. An ethyl acetate fraction of Artemisia capillaris (ACE-63) induced apoptosis and anti-angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma. Phytother. Res. 2018;32:2034\u20132046. doi: 10.1002/ptr.6135.", "ArticleIdList": ["10.1002/ptr.6135", "29972254"]}, {"Citation": "Weifeng T., Feng S., Xiangji L., Changqing S., Zhiquan Q., Huazhong Z., Peining Y., Yong Y., Mengchao W., Xiaoqing J., et al. Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine. 2011;18:158\u2013162. doi: 10.1016/j.phymed.2010.07.003.", "ArticleIdList": ["10.1016/j.phymed.2010.07.003", "20739158"]}, {"Citation": "Delle Monache S., Sanit\u00e0 P., Trapasso E., Ursino M.R., Dugo P., Russo M., Ferlazzo N., Calapai G., Angelucci A., Navarra M. Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juice. PLoS ONE. 2013;8:e61484. doi: 10.1371/journal.pone.0061484.", "ArticleIdList": ["10.1371/journal.pone.0061484", "PMC3628853", "23613861"]}, {"Citation": "Ferlazzo N., Cirmi S., Russo M., Trapasso E., Ursino M.R., Lombardo G.E., Gangemi S., Calapai G., Navarra M. NF-\u03baB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. Life Sci. 2016;146:81\u201391. doi: 10.1016/j.lfs.2015.12.040.", "ArticleIdList": ["10.1016/j.lfs.2015.12.040", "26764233"]}, {"Citation": "Dai Q., Yin Q., Wei L., Zhou Y., Qiao C., Guo Y., Wang X., Ma S., Lu N. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells. Mol. Carcinog. 2016;55:1275\u20131289. doi: 10.1002/mc.22369.", "ArticleIdList": ["10.1002/mc.22369", "26259145"]}, {"Citation": "Wei L., Dai Y., Zhou Y., He Z., Yao J., Zhao L., Guo Q., Yang L. Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression. Cell Death Dis. 2017;8:e2944. doi: 10.1038/cddis.2017.335.", "ArticleIdList": ["10.1038/cddis.2017.335", "PMC5550876", "28726775"]}, {"Citation": "Anand David A.V., Arulmoli R., Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn. Rev. 2016;10:84\u201389. doi: 10.4103/0973-7847.194044.", "ArticleIdList": ["10.4103/0973-7847.194044", "PMC5214562", "28082789"]}, {"Citation": "Xu D., Hu M.J., Wang Y.Q., Cui Y.L. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules. 2019;24:1123. doi: 10.3390/molecules24061123.", "ArticleIdList": ["10.3390/molecules24061123", "PMC6470739", "30901869"]}, {"Citation": "Maurya A.K., Vinayak M. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol. Biol. Rep. 2015;42:1419\u20131429. doi: 10.1007/s11033-015-3921-7.", "ArticleIdList": ["10.1007/s11033-015-3921-7", "26311153"]}, {"Citation": "Maurya A.K., Vinayak M. Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): Key role of quercetin in cancer prevention. Tumour Biol. 2015;36:8913\u20138924. doi: 10.1007/s13277-015-3634-5.", "ArticleIdList": ["10.1007/s13277-015-3634-5", "26076811"]}, {"Citation": "Wu H., Pan L., Gao C., Xu H., Li Y., Zhang L., Ma L., Meng L., Sun X., Qin H. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway. Molecules. 2019;24:1993. doi: 10.3390/molecules24101993.", "ArticleIdList": ["10.3390/molecules24101993", "PMC6572074", "31137633"]}, {"Citation": "Sundarraj K., Raghunath A., Panneerselvam L., Perumal E. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells. Biofactors. 2020;46:118\u2013135. doi: 10.1002/biof.1577.", "ArticleIdList": ["10.1002/biof.1577", "31634424"]}, {"Citation": "Jiang F., Mu J., Wang X., Ye X., Si L., Ning S., Li Z., Li Y. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells. PLoS ONE. 2014;9:e96698. doi: 10.1371/journal.pone.0096698.", "ArticleIdList": ["10.1371/journal.pone.0096698", "PMC4013140", "24806207"]}, {"Citation": "Hsieh M.J., Lin C.W., Yang S.F., Chen M.K., Chiou H.L. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-\u03baB and AP-1 activity in human liver cancer cells. Br. J. Pharmacol. 2014;171:3037\u20133050. doi: 10.1111/bph.12626.", "ArticleIdList": ["10.1111/bph.12626", "PMC4055204", "24641665"]}, {"Citation": "Gu Y., Zhu C.F., Iwamoto H., Chen J.S. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J. Gastroenterol. 2005;11:6512\u20136517. doi: 10.3748/wjg.v11.i41.6512.", "ArticleIdList": ["10.3748/wjg.v11.i41.6512", "PMC4355795", "16425425"]}, {"Citation": "Tong Y., Wang M., Huang H., Zhang J., Huang Y., Chen Y., Pan H. Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line. Exp. Ther. Med. 2019;18:3793\u20133800. doi: 10.3892/etm.2019.8027.", "ArticleIdList": ["10.3892/etm.2019.8027", "PMC6781792", "31611933"]}, {"Citation": "Seydi E., Salimi A., Rasekh H.R., Mohsenifar Z., Pourahmad J. Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting. Nutr. Cancer. 2018;70:594\u2013604. doi: 10.1080/01635581.2018.1460679.", "ArticleIdList": ["10.1080/01635581.2018.1460679", "29693446"]}, {"Citation": "Yang P.W., Lu Z.Y., Pan Q., Chen T.T., Feng X.J., Wang S.M., Pan Y.C., Zhu M.H., Zhang S.H. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1. Phytomedicine. 2019;57:18\u201329. doi: 10.1016/j.phymed.2018.10.027.", "ArticleIdList": ["10.1016/j.phymed.2018.10.027", "30668319"]}, {"Citation": "Peng W., Hu C., Shu Z., Han T., Qin L., Zheng C. Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53. Phytomedicine. 2015;22:730\u2013736. doi: 10.1016/j.phymed.2015.05.003.", "ArticleIdList": ["10.1016/j.phymed.2015.05.003", "26141759"]}, {"Citation": "Abd El Maksoud A.I., Taher R.F., Gaara A.H., Abdelrazik E., Keshk O.S., Elawdan K.A., Morsy S.E., Salah A., Khalil H. Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells. Front. Oncol. 2019;9:1220. doi: 10.3389/fonc.2019.01220.", "ArticleIdList": ["10.3389/fonc.2019.01220", "PMC6861212", "31781509"]}, {"Citation": "Liu H.X., Xu M.Q., Li S.P., Tian S., Guo M.X., Qi J.Y., He C.J., Zhao X.S. Jujube leaf green tea extracts inhibits hepatocellular carcinoma cells by activating AMPK. Oncotarget. 2017;8:110566\u2013110575. doi: 10.18632/oncotarget.22821.", "ArticleIdList": ["10.18632/oncotarget.22821", "PMC5746404", "29299169"]}, {"Citation": "Chen J., Chen L., Lu T., Xie Y., Li C., Jia Z., Cao J. ER\u03b136 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 2019;12:3222\u20133234.", "ArticleIdList": ["PMC6949832", "31934166"]}, {"Citation": "Bimonte S., Albino V., Piccirillo M., Nasto A., Molino C., Palaia R., Cascella M. Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: Experimental findings and translational perspectives. Drug Des. Devel. Ther. 2019;13:611\u2013621. doi: 10.2147/DDDT.S180079.", "ArticleIdList": ["10.2147/DDDT.S180079", "PMC6387605", "30858692"]}, {"Citation": "Zhang Q., Tang X., Lu Q., Zhang Z., Rao J., Le A.D. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther. 2006;5:1227\u20131238. doi: 10.1158/1535-7163.MCT-05-0490.", "ArticleIdList": ["10.1158/1535-7163.MCT-05-0490", "16731755"]}, {"Citation": "Zhang Y., Owusu L., Duan W., Jiang T., Zang S., Ahmed A., Xin Y. Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells. Int. J. Mol. Med. 2013;32:959\u2013964. doi: 10.3892/ijmm.2013.1446.", "ArticleIdList": ["10.3892/ijmm.2013.1446", "23863984"]}, {"Citation": "Chen L., Ye H.L., Zhang G., Yao W.M., Chen X.Z., Zhang F.C., Liang G. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells. PLoS ONE. 2014;9:e85771. doi: 10.1371/journal.pone.0085771.", "ArticleIdList": ["10.1371/journal.pone.0085771", "PMC3897495", "24465696"]}, {"Citation": "Sojoodi M., Wei L., Erstad D.J., Yamada S., Fujii T., Hirschfield H., Kim R.S., Lauwers G.Y., Lanuti M., Hoshida Y., et al. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma. Cancer Prev. Res. 2020;13:497\u2013508. doi: 10.1158/1940-6207.CAPR-19-0383.", "ArticleIdList": ["10.1158/1940-6207.CAPR-19-0383", "PMC8340141", "32253266"]}, {"Citation": "Tang Y., Cao J., Cai Z., An H., Li Y., Peng Y., Chen N., Luo A., Tao H., Li K. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine-induced liver cancer via inhibition of cell division cycle 25A. Mol. Med. Rep. 2020;22:3873\u20133885. doi: 10.3892/mmr.2020.11463.", "ArticleIdList": ["10.3892/mmr.2020.11463", "PMC7533491", "33000276"]}, {"Citation": "Liao S., Lin J., Liu J., Chen T., Xu M., Zheng J. Chemoprevention of elite tea variety CFT-1 rich in EGCG against chemically induced liver cancer in rats. Food Sci. Nutr. 2019;7:2647\u20132665. doi: 10.1002/fsn3.1121.", "ArticleIdList": ["10.1002/fsn3.1121", "PMC6694417", "31428352"]}, {"Citation": "Agioutantis P.C., Kotsikoris V., Kolisis F.N., Loutrari H. RNA-seq data analysis of stimulated hepatocellular carcinoma cells treated with epigallocatechin gallate and fisetin reveals target genes and action mechanisms. Comput. Struct. Biotechnol. J. 2020;18:686\u2013695. doi: 10.1016/j.csbj.2020.03.006.", "ArticleIdList": ["10.1016/j.csbj.2020.03.006", "PMC7113608", "32257052"]}, {"Citation": "Kang Q., Tong Y., Gowd V., Wang M., Chen F., Cheng K.W. Oral administration of EGCG solution equivalent to daily achievable dosages of regular tea drinkers effectively suppresses miR483-3p induced metastasis of hepatocellular carcinoma cells in mice. Food Funct. 2021;12:3381\u20133392. doi: 10.1039/D1FO00664A.", "ArticleIdList": ["10.1039/D1FO00664A", "33900350"]}, {"Citation": "Yang H., Wang M., Sun H., Zhu S., Jin J. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma. Pharmacology. 2019;104:267\u2013275. doi: 10.1159/000502076.", "ArticleIdList": ["10.1159/000502076", "31434088"]}, {"Citation": "Chen R.J., Kuo H.C., Cheng L.H., Lee Y.H., Chang W.T., Wang B.J., Wang Y.J., Cheng H.C. Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer. Int. J. Mol. Sci. 2018;19:287. doi: 10.3390/ijms19010287.", "ArticleIdList": ["10.3390/ijms19010287", "PMC5796233", "29346311"]}, {"Citation": "Qian Y.Y., Liu Z.S., Yan H.J., Yuan Y.F., Levenson A.S., Li K. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma. Biomed Pharmacother. 2018;101:852\u2013859. doi: 10.1016/j.biopha.2018.03.022.", "ArticleIdList": ["10.1016/j.biopha.2018.03.022", "29635894"]}, {"Citation": "Malhotra A., Bath S., Elbarbry F. An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol. Oxid Med. Cell Longev. 2015;2015:803971. doi: 10.1155/2015/803971.", "ArticleIdList": ["10.1155/2015/803971", "PMC4477248", "26180596"]}, {"Citation": "Aja I., Ruiz-Larrea M.B., Courtois A., Krisa S., Richard T., Ruiz-Sanz J.I. Screening of Natural Stilbene Oligomers from. Antioxidants. 2020;9:469. doi: 10.3390/antiox9060469.", "ArticleIdList": ["10.3390/antiox9060469", "PMC7346113", "32492881"]}, {"Citation": "Dai H., Li M., Yang W., Sun X., Wang P., Wang X., Su J., Hu X., Zhao M. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling. Aging. 2020;12:11717\u201311731. doi: 10.18632/aging.103338.", "ArticleIdList": ["10.18632/aging.103338", "PMC7343503", "32530437"]}, {"Citation": "Rawat D., Chhonker S.K., Naik R.A., Koiri R.K. Modulation of antioxidant enzymes, SIRT1 and NF-\u03baB by resveratrol and nicotinamide in alcohol-aflatoxin B1-induced hepatocellular carcinoma. J. Biochem. Mol. Toxicol. 2021;35:e22625. doi: 10.1002/jbt.22625.", "ArticleIdList": ["10.1002/jbt.22625", "32894639"]}, {"Citation": "Bishayee A., Barnes K.F., Bhatia D., Darvesh A.S., Carroll R.T. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev. Res. 2010;3:753\u2013763. doi: 10.1158/1940-6207.CAPR-09-0171.", "ArticleIdList": ["10.1158/1940-6207.CAPR-09-0171", "20501860"]}, {"Citation": "Dai W., Wang F., Lu J., Xia Y., He L., Chen K., Li J., Li S., Liu T., Zheng Y., et al. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice. Oncotarget. 2015;6:13703\u201313717. doi: 10.18632/oncotarget.3800.", "ArticleIdList": ["10.18632/oncotarget.3800", "PMC4537043", "25938543"]}, {"Citation": "Karabekir S.C., \u00d6zg\u00f6rg\u00fcl\u00fc A. Possible protective effects of resveratrol in hepatocellular carcinoma. Iran. J. Basic Med. Sci. 2020;23:71\u201378. doi: 10.22038/IJBMS.2019.36821.8774.", "ArticleIdList": ["10.22038/IJBMS.2019.36821.8774", "PMC7206832", "32405350"]}, {"Citation": "Rahman M., Almalki W.H., Afzal O., Alfawaz Altamimi A.S., Kazmi I., Al-Abbasi F.A., Choudhry H., Alenezi S.K., Barkat M.A., Beg S., et al. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation. Int. J. Nanomed. 2020;15:9283\u20139299. doi: 10.2147/IJN.S277545.", "ArticleIdList": ["10.2147/IJN.S277545", "PMC7695602", "33262588"]}, {"Citation": "Jagwani S., Jalalpure S., Dhamecha D., Jadhav K., Bohara R. Pharmacokinetic and Pharmacodynamic Evaluation of Resveratrol Loaded Cationic Liposomes for Targeting Hepatocellular Carcinoma. ACS Biomater. Sci. Eng. 2020;6:4969\u20134984. doi: 10.1021/acsbiomaterials.0c00429.", "ArticleIdList": ["10.1021/acsbiomaterials.0c00429", "33455290"]}, {"Citation": "Mohamed G.A., Al-Abd A.M., El-Halawany A.M., Abdallah H.M., Ibrahim S.R.M. New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines. J. Ethnopharmacol. 2017;198:302\u2013312. doi: 10.1016/j.jep.2017.01.030.", "ArticleIdList": ["10.1016/j.jep.2017.01.030", "28108382"]}, {"Citation": "Wudtiwai B., Pitchakarn P., Banjerdpongchai R. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells. Toxicol. In Vitro. 2018;53:222\u2013232. doi: 10.1016/j.tiv.2018.09.003.", "ArticleIdList": ["10.1016/j.tiv.2018.09.003", "30195041"]}, {"Citation": "Li M., Zhang M., Zhang Z.L., Liu N., Han X.Y., Liu Q.C., Deng W.J., Liao C.X. Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-\u03baB. Oncol. Res. 2017;25:233\u2013239. doi: 10.3727/096504016X14742891049073.", "ArticleIdList": ["10.3727/096504016X14742891049073", "PMC7840840", "28277195"]}, {"Citation": "Yoon J.S., Kim H.M., Yadunandam A.K., Kim N.H., Jung H.A., Choi J.S., Kim C.Y., Kim G.D. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: Molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response. Phytomedicine. 2013;20:1013\u20131022. doi: 10.1016/j.phymed.2013.03.024.", "ArticleIdList": ["10.1016/j.phymed.2013.03.024", "23746959"]}, {"Citation": "Guo Q.L., You Q.D., Wu Z.Q., Yuan S.T., Zhao L. General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol. Sin. 2004;25:769\u2013774.", "ArticleIdList": ["15169630"]}, {"Citation": "Yan F., Wang M., Li J., Cheng H., Su J., Wang X., Wu H., Xia L., Li X., Chang H.C., et al. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells. Environ. Toxicol. Pharmacol. 2012;33:181\u2013190. doi: 10.1016/j.etap.2011.12.006.", "ArticleIdList": ["10.1016/j.etap.2011.12.006", "22222560"]}, {"Citation": "Duan D., Zhang B., Yao J., Liu Y., Sun J., Ge C., Peng S., Fang J. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase. Free Radic. Biol. Med. 2014;69:15\u201325. doi: 10.1016/j.freeradbiomed.2013.12.027.", "ArticleIdList": ["10.1016/j.freeradbiomed.2013.12.027", "24407164"]}, {"Citation": "Munakarmi S., Chand L., Shin H.B., Hussein U.K., Yun B.S., Park H.R., Jeong Y.J. Anticancer effects of Poncirus fructus on hepatocellular carcinoma through regulation of apoptosis, migration, and invasion. Oncol. Rep. 2020;44:2537\u20132546. doi: 10.3892/or.2020.7790.", "ArticleIdList": ["10.3892/or.2020.7790", "PMC7640358", "33125135"]}, {"Citation": "Kato R., Matsui-Yuasa I., Azuma H., Kojima-Yuasa A. The synergistic effect of 1\u2032-acetoxychavicol acetate and sodium butyrate on the death of human hepatocellular carcinoma cells. Chem. Biol. Interact. 2014;212:1\u201310. doi: 10.1016/j.cbi.2014.01.010.", "ArticleIdList": ["10.1016/j.cbi.2014.01.010", "24480522"]}, {"Citation": "Li Q., Li Y., Wang X., Fang X., He K., Guo X., Zhan Z., Sun C., Jin Y.H. Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release. Mol. Carcinog. 2011;50:760\u2013769. doi: 10.1002/mc.20673.", "ArticleIdList": ["10.1002/mc.20673", "21751259"]}, {"Citation": "Li M., Shang H., Wang T., Yang S.Q., Li L. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing. World J. Gastroenterol. 2021;27:939\u2013958. doi: 10.3748/wjg.v27.i10.939.", "ArticleIdList": ["10.3748/wjg.v27.i10.939", "PMC7968131", "33776365"]}, {"Citation": "Huang J., Guo W., Cheung F., Tan H.Y., Wang N., Feng Y. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma. Am. J. Chin. Med. 2020;48:161\u2013182. doi: 10.1142/S0192415X20500093.", "ArticleIdList": ["10.1142/S0192415X20500093", "31964157"]}, {"Citation": "Wang N., Feng Y., Tan H.Y., Cheung F., Hong M., Lao L., Nagamatsu T. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma. J. Ethnopharmacol. 2015;164:309\u2013318. doi: 10.1016/j.jep.2015.02.025.", "ArticleIdList": ["10.1016/j.jep.2015.02.025", "25700642"]}, {"Citation": "Matsui Y., Uhara J., Satoi S., Kaibori M., Yamada H., Kitade H., Imamura A., Takai S., Kawaguchi Y., Kwon A.H., et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: A prospective cohort study. J. Hepatol. 2002;37:78\u201386. doi: 10.1016/S0168-8278(02)00091-0.", "ArticleIdList": ["10.1016/S0168-8278(02)00091-0", "12076865"]}, {"Citation": "Mabed M., El-Helw L., Shamaa S. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma. Br. J. Cancer. 2004;90:65\u201369. doi: 10.1038/sj.bjc.6601463.", "ArticleIdList": ["10.1038/sj.bjc.6601463", "PMC2395314", "14710208"]}, {"Citation": "Zhou B., Yan Z., Liu R., Shi P., Qian S., Qu X., Zhu L., Zhang W., Wang J. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. Radiology. 2016;280:630\u2013639. doi: 10.1148/radiol.2016150719.", "ArticleIdList": ["10.1148/radiol.2016150719", "26885681"]}, {"Citation": "Wang Z., Yu X.L., Zhang J., Cheng Z.G., Han Z.Y., Liu F.Y., Dou J.P., Kong Y., Dong X.J., Zhao Q.X., et al. Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study. J. Ethnopharmacol. 2021;281:114539. doi: 10.1016/j.jep.2021.114539.", "ArticleIdList": ["10.1016/j.jep.2021.114539", "34428522"]}, {"Citation": "Fan Y., Li S., Ding X., Yue J., Jiang J., Zhao H., Hao R., Qiu W., Liu K., Li Y., et al. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers. BMC Cancer. 2019;19:279. doi: 10.1186/s12885-019-5471-1.", "ArticleIdList": ["10.1186/s12885-019-5471-1", "PMC6437929", "30922248"]}, {"Citation": "O\u2019Reilly E.M., Stuart K.E., Sanz-Altamira P.M., Schwartz G.K., Steger C.M., Raeburn L., Kemeny N.E., Kelsen D.P., Saltz L.B. A phase II study of irinotecan in patients with advanced hepatocellular carcinoma. Cancer. 2001;91:101\u2013105. doi: 10.1002/1097-0142(20010101)91:1<101::AID-CNCR13>3.0.CO;2-K.", "ArticleIdList": ["10.1002/1097-0142(20010101)91:1<101::AID-CNCR13>3.0.CO;2-K", "11148565"]}, {"Citation": "Brandi G., Biasco G., Mirarchi M.G., Golfieri R., Di Paolo A., Borghi A., Fanello S., Derenzini E., Agostini V., Giampalma E., et al. A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. Dig. Liver Dis. 2011;43:1015\u20131021. doi: 10.1016/j.dld.2011.08.005.", "ArticleIdList": ["10.1016/j.dld.2011.08.005", "21917536"]}, {"Citation": "Zhong C., Li H.D., Liu D.Y., Xu F.B., Wu J., Lin X.M., Guo R.P. Clinical study of hepatectomy combined with Jianpi Huayu Therapy for hepatocellular carcinoma. Asian Pac. J. Cancer Prev. 2014;15:5951\u20135957. doi: 10.7314/APJCP.2014.15.14.5951.", "ArticleIdList": ["10.7314/APJCP.2014.15.14.5951", "25081728"]}, {"Citation": "Tang C.W., Zhu M., Feng W.M., Bao Y., Zheng Y.Y. Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: A retrospective study. Drug Des. Devel. Ther. 2016;10:2461\u20132466. doi: 10.2147/DDDT.S113295.", "ArticleIdList": ["10.2147/DDDT.S113295", "PMC4977068", "27536066"]}, {"Citation": "Tang C., Feng W., Qin L., Bao Y. Chinese Herbal Medicine, Jian Pi Li Gan Decoction, Improved Survival of Nonresectable Hepatocellular Cancer After Radiofrequency Ablation: A Retrospective Study. Integr. Cancer Ther. 2018;17:431\u2013436. doi: 10.1177/1534735417722223.", "ArticleIdList": ["10.1177/1534735417722223", "PMC6041913", "28745082"]}, {"Citation": "Wang J., Luo J., Yin X., Huang W., Cao H., Wang G., Zhou J. Jiedu Granule Combined with Transcatheter Arterial Chemoembolization and Gamma Knife Radiosurgery in Treating Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Biomed Res. Int. 2019;2019:4696843. doi: 10.1155/2019/4696843.", "ArticleIdList": ["10.1155/2019/4696843", "PMC6614979", "31341898"]}, {"Citation": "Zhai X.F., Liu X.L., Shen F., Fan J., Ling C.Q. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer. 2018;124:2161\u20132168. doi: 10.1002/cncr.30915.", "ArticleIdList": ["10.1002/cncr.30915", "29499082"]}, {"Citation": "Lau W.Y., Lai E.C., Leung T.W., Yu S.C. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: A prospective randomized trial-update on 5-year and 10-year survival. Ann. Surg. 2008;247:43\u201348. doi: 10.1097/SLA.0b013e3181571047.", "ArticleIdList": ["10.1097/SLA.0b013e3181571047", "18156922"]}, {"Citation": "Lintia-Gaultier A., Perret C., Ansquer C., Eug\u00e8ne T., Kraeber-Bod\u00e9r\u00e9 F., Frampas E. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: A 7 years\u2019 experience. Nucl. Med. Commun. 2013;34:674\u2013681. doi: 10.1097/MNM.0b013e32836141a0.", "ArticleIdList": ["10.1097/MNM.0b013e32836141a0", "23587835"]}, {"Citation": "Zhou B., Shan H., Zhu K.S., Jiang Z.B., Guan S.H., Meng X.C., Zeng X.C. Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation. J. Vasc. Interv. Radiol. 2010;21:333\u2013338. doi: 10.1016/j.jvir.2009.11.006.", "ArticleIdList": ["10.1016/j.jvir.2009.11.006", "20116286"]}, {"Citation": "Strumberg D., Erhard J., Harstrick A., Klaassen U., M\u00fcller C., Eberhardt W., Wilke H., Seeber S. Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinoma. Eur. J. Cancer. 1998;34:1290\u20131292. doi: 10.1016/S0959-8049(98)00054-9.", "ArticleIdList": ["10.1016/S0959-8049(98)00054-9", "9849493"]}, {"Citation": "Lin J.J., Jin C.N., Zheng M.L., Ouyang X.N., Zeng J.X., Dai X.H. Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation. Chin. J. Integr. Med. 2005;11:104\u2013110. doi: 10.1007/BF02836465.", "ArticleIdList": ["10.1007/BF02836465", "16150196"]}, {"Citation": "Huang Z., Wang Y., Chen J., Wang R., Chen Q. Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients. J. Tradit. Chin. Med. 2013;33:34\u201338. doi: 10.1016/S0254-6272(13)60097-7.", "ArticleIdList": ["10.1016/S0254-6272(13)60097-7", "23596809"]}, {"Citation": "Chay W.Y., Tham C.K., Toh H.C., Lim H.Y., Tan C.K., Lim C., Wang W.W., Choo S.P. Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy. J. Altern. Complement. Med. 2017;23:648\u2013652. doi: 10.1089/acm.2016.0136.", "ArticleIdList": ["10.1089/acm.2016.0136", "28375640"]}, {"Citation": "Sarker U., Oba S. Nutraceuticals, antioxidant pigments, and phytochemicals in the leaves of Amaranthus spinosus and Amaranthus viridis weedy species. Sci. Rep. 2019;9:20413. doi: 10.1038/s41598-019-50977-5.", "ArticleIdList": ["10.1038/s41598-019-50977-5", "PMC6938518", "31892700"]}, {"Citation": "Sharma J., Gairola S., Gaur R.D., Painuli R.M. The treatment of jaundice with medicinal plants in indigenous communities of the Sub-Himalayan region of Uttarakhand, India. J. Ethnopharmacol. 2012;143:262\u2013291. doi: 10.1016/j.jep.2012.06.034.", "ArticleIdList": ["10.1016/j.jep.2012.06.034", "22759701"]}, {"Citation": "Mondal A., Guria T., Maity T.K. A new ester of fatty acid from a methanol extract of the whole plant of Amaranthus spinosus and its \u03b1-glucosidase inhibitory activity. Pharm. Biol. 2015;53:600\u2013604. doi: 10.3109/13880209.2014.935863.", "ArticleIdList": ["10.3109/13880209.2014.935863", "25339411"]}, {"Citation": "Amuthan A., Chogtu B., Bairy K.L., Prakash M. Evaluation of diuretic activity of Amaranthus spinosus Linn. aqueous extract in Wistar rats. J. Ethnopharmacol. 2012;140:424\u2013427. doi: 10.1016/j.jep.2012.01.049.", "ArticleIdList": ["10.1016/j.jep.2012.01.049", "22331031"]}, {"Citation": "Chaudhary M.A., Imran I., Bashir S., Mehmood M.H., Rehman N.U., Gilani A.H. Evaluation of gut modulatory and bronchodilator activities of Amaranthus spinosus Linn. BMC Complement. Altern. Med. 2012;12:166. doi: 10.1186/1472-6882-12-166.", "ArticleIdList": ["10.1186/1472-6882-12-166", "PMC3545920", "23025418"]}, {"Citation": "Mondal A., Maity T.K. Antibacterial activity of a novel fatty acid (14E, 18E, 22E, 26E)-methyl nonacosa-14, 18, 22, 26 tetraenoate isolated from Amaranthus spinosus. Pharm. Biol. 2016;54:2364\u20132367. doi: 10.3109/13880209.2016.1155628.", "ArticleIdList": ["10.3109/13880209.2016.1155628", "27043360"]}, {"Citation": "Leung W.T., Lau W.Y., Ho S., Chan M., Leung N., Lin J., Ho K.C., Metreweli C., Johnson P.J., Li A.K. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J. Nucl. Med. 1994;35:1313\u20131318.", "ArticleIdList": ["7519259"]}, {"Citation": "Mani J.S., Johnson J.B., Hosking H., Ashwath N., Walsh K.B., Neilsen P.M., Broszczak D.A., Naiker M. Antioxidative and therapeutic potential of selected Australian plants: A review. J. Ethnopharmacol. 2021;268:113580. doi: 10.1016/j.jep.2020.113580.", "ArticleIdList": ["10.1016/j.jep.2020.113580", "33189842"]}, {"Citation": "Arnesen J.A., Kildegaard K.R., Cernuda Pastor M., Jayachandran S., Kristensen M., Borodina I. Strains Engineered for the Production of Terpenoids. Front. Bioeng. Biotechnol. 2020;8:945. doi: 10.3389/fbioe.2020.00945.", "ArticleIdList": ["10.3389/fbioe.2020.00945", "PMC7456906", "32923433"]}, {"Citation": "Jiang M., Wu Z., Guo H., Liu L., Chen S. A Review of Terpenes from Marine-Derived Fungi: 2015\u20132019. Mar. Drugs. 2020;18:321. doi: 10.3390/md18060321.", "ArticleIdList": ["10.3390/md18060321", "PMC7345631", "32570903"]}, {"Citation": "Hillier S.G., Lathe R. Terpenes, hormones and life: Isoprene rule revisited. J. Endocrinol. 2019;242:R9\u2013R22. doi: 10.1530/JOE-19-0084.", "ArticleIdList": ["10.1530/JOE-19-0084", "31051473"]}, {"Citation": "Firn R.D., Jones C.G. Natural products--a simple model to explain chemical diversity. Nat. Prod. Rep. 2003;20:382\u2013391. doi: 10.1039/b208815k.", "ArticleIdList": ["10.1039/b208815k", "12964834"]}, {"Citation": "Thoppil R.J., Bishayee A. Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World J. Hepatol. 2011;3:228\u2013249. doi: 10.4254/wjh.v3.i9.228.", "ArticleIdList": ["10.4254/wjh.v3.i9.228", "PMC3182282", "21969877"]}, {"Citation": "Dasgupta A., Acharya K. Mushrooms: An emerging resource for therapeutic terpenoids. 3 Biotech. 2019;9:369. doi: 10.1007/s13205-019-1906-2.", "ArticleIdList": ["10.1007/s13205-019-1906-2", "PMC6760460", "31588393"]}, {"Citation": "Sullivan R., Smith J.E., Rowan N.J. Medicinal mushrooms and cancer therapy: Translating a traditional practice into Western medicine. Perspect. Biol. Med. 2006;49:159\u2013170. doi: 10.1353/pbm.2006.0034.", "ArticleIdList": ["10.1353/pbm.2006.0034", "16702701"]}, {"Citation": "Standish L.J., Wenner C.A., Sweet E.S., Bridge C., Nelson A., Martzen M., Novack J., Torkelson C. Trametes versicolor mushroom immune therapy in breast cancer. J. Soc. Integr. Oncol. 2008;6:122\u2013128.", "ArticleIdList": ["PMC2845472", "19087769"]}, {"Citation": "PDQ Cancer Information Summaries.  [(accessed on 10 November 2021)];2002  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK82221/"}, {"Citation": "Gao Q.H., Wu C.S., Wang M. The jujube (Ziziphus jujuba Mill.) fruit: A review of current knowledge of fruit composition and health benefits. J. Agric. Food Chem. 2013;61:3351\u20133363. doi: 10.1021/jf4007032.", "ArticleIdList": ["10.1021/jf4007032", "23480594"]}, {"Citation": "Liu J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 1995;49:57\u201368. doi: 10.1016/0378-8741(95)90032-2.", "ArticleIdList": ["10.1016/0378-8741(95)90032-2", "8847885"]}, {"Citation": "Yan S.L., Huang C.Y., Wu S.T., Yin M.C. Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicol. In Vitro. 2010;24:842\u2013848. doi: 10.1016/j.tiv.2009.12.008.", "ArticleIdList": ["10.1016/j.tiv.2009.12.008", "20005942"]}, {"Citation": "Yang Y., Qiu S., Qian L., Tian Y., Chen Y., Bi L., Chen W. OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells. PLoS ONE. 2017;12:e0174021. doi: 10.1371/journal.pone.0174021.", "ArticleIdList": ["10.1371/journal.pone.0174021", "PMC5354425", "28301605"]}, {"Citation": "Wojcikowski K., Gobe G. Animal studies on medicinal herbs: Predictability, dose conversion and potential value. Phytother. Res. 2014;28:22\u201327. doi: 10.1002/ptr.4966.", "ArticleIdList": ["10.1002/ptr.4966", "23553964"]}, {"Citation": "Xiong J., Cheng G., Tang H., Zhen H.N., Zhang X. Ardipusilloside I induces apoptosis in human glioblastoma cells through a caspase-8-independent FasL/Fas-signaling pathway. Environ. Toxicol. Pharmacol. 2009;27:264\u2013270. doi: 10.1016/j.etap.2008.11.008.", "ArticleIdList": ["10.1016/j.etap.2008.11.008", "21783950"]}, {"Citation": "Talevi A., Quiroga A.M.P. ADME Processes in Pharmaceutical Sciences. Springer; Cham, Switzerland: 2018."}, {"Citation": "Raj Marshall G., Raveendran R. Introduction to Basics of Pharmacology and Toxicology. General and Molecular Pharmacology: Principles of Drug Action. Volume 1 Springer; Singapore: 2019."}, {"Citation": "Reddy D., Kumavath R., Ghosh P., Barh D. Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways. Biomolecules. 2019;9:792. doi: 10.3390/biom9120792.", "ArticleIdList": ["10.3390/biom9120792", "PMC6995510", "31783627"]}, {"Citation": "Chen L.I., Guo Y., Alsaif G., Gao Y. Total Flavonoids Isolated from. Anticancer Res. 2020;40:5201\u20135210. doi: 10.21873/anticanres.14523.", "ArticleIdList": ["10.21873/anticanres.14523", "32878808"]}, {"Citation": "Zhu A.K., Zhou H., Xia J.Z., Jin H.C., Wang K., Yan J., Zuo J.B., Zhu X., Shan T. Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway. Braz. J. Med. Biol. Res. 2013;46:670\u2013675. doi: 10.1590/1414-431X20133050.", "ArticleIdList": ["10.1590/1414-431X20133050", "PMC3854423", "23969976"]}, {"Citation": "Zhu X., Wang K., Zhang K., Huang B., Zhang J., Zhang Y., Zhu L., Zhou B., Zhou F. Ziyuglycoside II inhibits the growth of human breast carcinoma MDA-MB-435 cells via cell cycle arrest and induction of apoptosis through the mitochondria dependent pathway. Int. J. Mol. Sci. 2013;14:18041\u201318055. doi: 10.3390/ijms140918041.", "ArticleIdList": ["10.3390/ijms140918041", "PMC3794768", "24005866"]}, {"Citation": "Lkhagvasuren K., Kim J.K. Ziyuglycoside II induces caspases-dependent and caspases-independent apoptosis in human colon cancer cells. Toxicol. In Vitro. 2019;59:255\u2013262. doi: 10.1016/j.tiv.2019.04.028.", "ArticleIdList": ["10.1016/j.tiv.2019.04.028", "31029785"]}, {"Citation": "Chen H.M., Lai Z.Q., Liao H.J., Xie J.H., Xian Y.F., Chen Y.L., Ip S.P., Lin Z.X., Su Z.R. Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells. Int. J. Mol. Med. 2018;41:1447\u20131454. doi: 10.3892/ijmm.2018.3372.", "ArticleIdList": ["10.3892/ijmm.2018.3372", "PMC5819912", "29328398"]}, {"Citation": "Vartanian S., Ma T.P., Lee J., Haverty P.M., Kirkpatrick D.S., Yu K., Stokoe D. Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis. Mol. Cell. Proteom. 2016;15:1220\u20131231. doi: 10.1074/mcp.M115.055509.", "ArticleIdList": ["10.1074/mcp.M115.055509", "PMC4824851", "26711467"]}, {"Citation": "Lu Z., Lai Z.Q., Leung A.W.N., Leung P.S., Li Z.S., Lin Z.X. Exploring brusatol as a new anti-pancreatic cancer adjuvant: Biological evaluation and mechanistic studies. Oncotarget. 2017;8:84974\u201384985. doi: 10.18632/oncotarget.17761.", "ArticleIdList": ["10.18632/oncotarget.17761", "PMC5689587", "29156697"]}, {"Citation": "Krishna S., Bustamante L., Haynes R.K., Staines H.M. Artemisinins: Their growing importance in medicine. Trends Pharmacol. Sci. 2008;29:520\u2013527. doi: 10.1016/j.tips.2008.07.004.", "ArticleIdList": ["10.1016/j.tips.2008.07.004", "PMC2758403", "18752857"]}, {"Citation": "Farrar M.C., Jacobs T.F. Paclitaxel. StatPearls Publishing; Treasure Island, FL, USA: 2021."}, {"Citation": "Kim J.W., Jung S.Y., Kwon Y.H., Lee S.H., Lee J.H., Lee B.Y., Kwon S.M. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent Akt/eNOS signaling. Phytother. Res. 2012;26:1286\u20131293. doi: 10.1002/ptr.3722.", "ArticleIdList": ["10.1002/ptr.3722", "22253055"]}, {"Citation": "Chen Q.J., Zhang M.Z., Wang L.X. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell Physiol. Biochem. 2010;26:849\u2013858. doi: 10.1159/000323994.", "ArticleIdList": ["10.1159/000323994", "21220916"]}, {"Citation": "Hu S., Zhu Y., Xia X., Xu X., Chen F., Miao X., Chen X. Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis. Anal. Cell Pathol. 2019;2019:3815786. doi: 10.1155/2019/3815786.", "ArticleIdList": ["10.1155/2019/3815786", "PMC6732603", "31534898"]}, {"Citation": "Zhao Q., Li P., Jiang J., Hu P. Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers. Eur. J. Drug Metab. Pharmacokinet. 2016;41:845\u2013853. doi: 10.1007/s13318-015-0304-3.", "ArticleIdList": ["10.1007/s13318-015-0304-3", "26470874"]}, {"Citation": "Ganesan K., Xu B. A Critical Review on Polyphenols and Health Benefits of Black Soybeans. Nutrients. 2017;9:455. doi: 10.3390/nu9050455.", "ArticleIdList": ["10.3390/nu9050455", "PMC5452185", "28471393"]}, {"Citation": "Dai J., Mumper R.J. Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Molecules. 2010;15:7313\u20137352. doi: 10.3390/molecules15107313.", "ArticleIdList": ["10.3390/molecules15107313", "PMC6259146", "20966876"]}, {"Citation": "Anantharaju P.G., Gowda P.C., Vimalambike M.G., Madhunapantula S.V. An overview on the role of dietary phenolics for the treatment of cancers. Nutr. J. 2016;15:99. doi: 10.1186/s12937-016-0217-2.", "ArticleIdList": ["10.1186/s12937-016-0217-2", "PMC5131407", "27903278"]}, {"Citation": "Kikuchi H., Yuan B., Hu X., Okazaki M. Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents. Am. J. Cancer Res. 2019;9:1517\u20131535.", "ArticleIdList": ["PMC6726994", "31497340"]}, {"Citation": "Abotaleb M., Samuel S.M., Varghese E., Varghese S., Kubatka P., Liskova A., B\u00fcsselberg D. Flavonoids in Cancer and Apoptosis. Cancers. 2018;11:28. doi: 10.3390/cancers11010028.", "ArticleIdList": ["10.3390/cancers11010028", "PMC6357032", "30597838"]}, {"Citation": "Banjerdpongchai R., Wudtiwai B., Khaw-On P., Rachakhom W., Duangnil N., Kongtawelert P. Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol. 2016;37:227\u2013237. doi: 10.1007/s13277-015-3774-7.", "ArticleIdList": ["10.1007/s13277-015-3774-7", "PMC4841854", "26194866"]}, {"Citation": "Wang Z., Zhang H., Zhou J., Zhang X., Chen L., Chen K., Huang Z. Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle. Cancer Chemother. Pharmacol. 2016;78:1143\u20131150. doi: 10.1007/s00280-016-3171-y.", "ArticleIdList": ["10.1007/s00280-016-3171-y", "27766389"]}, {"Citation": "Xie D., Yuan P., Wang D., Jin H., Chen H. Effects of naringin on the expression of miR-19b and cell apoptosis in human hepatocellular carcinoma. Oncol. Lett. 2017;14:1455\u20131459. doi: 10.3892/ol.2017.6278.", "ArticleIdList": ["10.3892/ol.2017.6278", "PMC5529873", "28789364"]}, {"Citation": "Kuo C.J., Conley P.B., Chen L., Sladek F.M., Darnell J.E., Crabtree G.R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature. 1992;355:457\u2013461. doi: 10.1038/355457a0.", "ArticleIdList": ["10.1038/355457a0", "1734282"]}, {"Citation": "Saha S.K., Parachoniak C.A., Ghanta K.S., Fitamant J., Ross K.N., Najem M.S., Gurumurthy S., Akbay E.A., Sia D., Cornella H., et al. Mutant IDH inhibits HNF-4\u03b1 to block hepatocyte differentiation and promote biliary cancer. Nature. 2014;513:110\u2013114. doi: 10.1038/nature13441.", "ArticleIdList": ["10.1038/nature13441", "PMC4499230", "25043045"]}, {"Citation": "Lincet H., Icard P. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? Oncogene. 2015;34:3751\u20133759. doi: 10.1038/onc.2014.320.", "ArticleIdList": ["10.1038/onc.2014.320", "25263450"]}, {"Citation": "Mayer D., Klimek F., Rempel A., Bannasch P. Hexokinase expression in liver preneoplasia and neoplasia. Biochem. Soc. Trans. 1997;25:122\u2013127. doi: 10.1042/bst0250122.", "ArticleIdList": ["10.1042/bst0250122", "9056856"]}, {"Citation": "Arai Y., Watanabe S., Kimira M., Shimoi K., Mochizuki R., Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 2000;130:2243\u20132250. doi: 10.1093/jn/130.9.2243.", "ArticleIdList": ["10.1093/jn/130.9.2243", "10958819"]}, {"Citation": "Hanneken A., Lin F.F., Johnson J., Maher P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Investig. Ophthalmol. Vis. Sci. 2006;47:3164\u20133177. doi: 10.1167/iovs.04-1369.", "ArticleIdList": ["10.1167/iovs.04-1369", "16799064"]}, {"Citation": "Salmela A.L., Pouwels J., Varis A., Kukkonen A.M., Toivonen P., Halonen P.K., Per\u00e4l\u00e4 M., Kallioniemi O., Gorbsky G.J., Kallio M.J. Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint. Carcinogenesis. 2009;30:1032\u20131040. doi: 10.1093/carcin/bgp101.", "ArticleIdList": ["10.1093/carcin/bgp101", "PMC2691139", "19395653"]}, {"Citation": "Khan N., Afaq F., Syed D.N., Mukhtar H. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis. 2008;29:1049\u20131056. doi: 10.1093/carcin/bgn078.", "ArticleIdList": ["10.1093/carcin/bgn078", "PMC2902387", "18359761"]}, {"Citation": "Youns M., Abdel Halim Hegazy W. The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways. PLoS ONE. 2017;12:e0169335. doi: 10.1371/journal.pone.0169335.", "ArticleIdList": ["10.1371/journal.pone.0169335", "PMC5215656", "28052097"]}, {"Citation": "Lee S.R., Kwon S.W., Lee Y.H., Kaya P., Kim J.M., Ahn C., Jung E.M., Lee G.S., An B.S., Jeung E.B., et al. Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation. BMC Cancer. 2019;19:6. doi: 10.1186/s12885-018-5222-8.", "ArticleIdList": ["10.1186/s12885-018-5222-8", "PMC6318960", "30606143"]}, {"Citation": "Zhang L., Liu P., Li L., Huang Y., Pu Y., Hou X., Song L. Identification and Antioxidant Activity of Flavonoids Extracted from Xinjiang Jujube. Molecules. 2018;24:122. doi: 10.3390/molecules24010122.", "ArticleIdList": ["10.3390/molecules24010122", "PMC6337089", "30598032"]}, {"Citation": "Zhou J., Wu J., Chen X., Fortenbery N., Eksioglu E., Kodumudi K.N., Pk E.B., Dong J., Djeu J.Y., Wei S. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int. Immunopharmacol. 2011;11:890\u2013898. doi: 10.1016/j.intimp.2011.01.007.", "ArticleIdList": ["10.1016/j.intimp.2011.01.007", "PMC3109231", "21244860"]}, {"Citation": "Zhao H., Guo Y., Li S., Han R., Ying J., Zhu H., Wang Y., Yin L., Han Y., Sun L., et al. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Oncotarget. 2015;6:31927\u201331943. doi: 10.18632/oncotarget.5578.", "ArticleIdList": ["10.18632/oncotarget.5578", "PMC4741651", "26376676"]}, {"Citation": "Luo X.Y., Wu K.M., He X.X. Advances in drug development for hepatocellular carcinoma: Clinical trials and potential therapeutic targets. J. Exp. Clin. Cancer Res. 2021;40:172. doi: 10.1186/s13046-021-01968-w.", "ArticleIdList": ["10.1186/s13046-021-01968-w", "PMC8130401", "34006331"]}, {"Citation": "Nakagawa S., Wei L., Song W.M., Higashi T., Ghoshal S., Kim R.S., Bian C.B., Yamada S., Sun X., Venkatesh A., et al. Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. Cancer Cell. 2016;30:879\u2013890. doi: 10.1016/j.ccell.2016.11.004.", "ArticleIdList": ["10.1016/j.ccell.2016.11.004", "PMC5161110", "27960085"]}, {"Citation": "McCormack D., McFadden D. Pterostilbene and cancer: Current review. J. Surg. Res. 2012;173:e53\u2013e61. doi: 10.1016/j.jss.2011.09.054.", "ArticleIdList": ["10.1016/j.jss.2011.09.054", "22099605"]}, {"Citation": "Paoli P., Giannoni E., Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim. Biophys. Acta. 2013;1833:3481\u20133498. doi: 10.1016/j.bbamcr.2013.06.026.", "ArticleIdList": ["10.1016/j.bbamcr.2013.06.026", "23830918"]}, {"Citation": "Yang S., Zhou F., Dong Y., Ren F. \u03b1-Mangostin Induces Apoptosis in Human Osteosarcoma Cells Through ROS-Mediated Endoplasmic Reticulum Stress via the WNT Pathway. Cell Transplant. 2021;30:9636897211035080. doi: 10.1177/09636897211035080.", "ArticleIdList": ["10.1177/09636897211035080", "PMC8323427", "34318699"]}, {"Citation": "Panthong A., Norkaew P., Kanjanapothi D., Taesotikul T., Anantachoke N., Reutrakul V. Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook f. J. Ethnopharmacol. 2007;111:335\u2013340. doi: 10.1016/j.jep.2006.11.038.", "ArticleIdList": ["10.1016/j.jep.2006.11.038", "17360136"]}, {"Citation": "Qiu S., Sun H., Zhang A.H., Xu H.Y., Yan G.L., Han Y., Wang X.J. Natural alkaloids: Basic aspects, biological roles, and future perspectives. Chin. J. Nat. Med. 2014;12:401\u2013406. doi: 10.1016/S1875-5364(14)60063-7.", "ArticleIdList": ["10.1016/S1875-5364(14)60063-7", "24969519"]}, {"Citation": "Setiawan V.W., Wilkens L.R., Lu S.C., Hernandez B.Y., Le Marchand L., Henderson B.E. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology. 2015;148:118\u2013125. doi: 10.1053/j.gastro.2014.10.005.", "ArticleIdList": ["10.1053/j.gastro.2014.10.005", "PMC4274222", "25305507"]}, {"Citation": "Liu F., Wang X., Wu G., Chen L., Hu P., Ren H., Hu H. Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis. PLoS ONE. 2015;10:e0142457. doi: 10.1371/journal.pone.0142457.", "ArticleIdList": ["10.1371/journal.pone.0142457", "PMC4640566", "26556483"]}, {"Citation": "Cavin C., Marin-Kuan M., Langou\u00ebt S., Bezen\u00e7on C., Guignard G., Verguet C., Piguet D., Holzh\u00e4user D., Cornaz R., Schilter B. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem. Toxicol. 2008;46:1239\u20131248. doi: 10.1016/j.fct.2007.09.099.", "ArticleIdList": ["10.1016/j.fct.2007.09.099", "17976884"]}, {"Citation": "Petrick J.L., Freedman N.D., Graubard B.I., Sahasrabuddhe V.V., Lai G.Y., Alavanja M.C., Beane-Freeman L.E., Boggs D.A., Buring J.E., Chan A.T., et al. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. Cancer Epidemiol. Biomark. Prev. 2015;24:1398\u20131406. doi: 10.1158/1055-9965.EPI-15-0137.", "ArticleIdList": ["10.1158/1055-9965.EPI-15-0137", "PMC4576990", "26126626"]}, {"Citation": "Bamia C., Lagiou P., Jenab M., Trichopoulou A., Fedirko V., Aleksandrova K., Pischon T., Overvad K., Olsen A., Tj\u00f8nneland A., et al. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study. Int. J. Cancer. 2015;136:1899\u20131908. doi: 10.1002/ijc.29214.", "ArticleIdList": ["10.1002/ijc.29214", "PMC6284785", "25219573"]}, {"Citation": "Wang H., Mu W., Shang H., Lin J., Lei X. The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: A review of systematic reviews and pharmacological research. Biomed Res. Int. 2014;2014:798093. doi: 10.1155/2014/798093.", "ArticleIdList": ["10.1155/2014/798093", "PMC4003828", "24818152"]}, {"Citation": "Reyhanoglu G., Smith T. Irinotecan. StatPearls Publishing; Treasure Island, FL, USA: 2021.", "ArticleIdList": ["32119328"]}, {"Citation": "Matsushita K., Kuramitsu Y., Ohiro Y., Obara M., Kobayashi M., Li Y.Q., Hosokawa M. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs. 1998;9:343\u2013350. doi: 10.1097/00001813-199804000-00008.", "ArticleIdList": ["10.1097/00001813-199804000-00008", "9635925"]}, {"Citation": "Shin M.S., Park H.J., Maeda T., Nishioka H., Fujii H., Kang I. The Effects of AHCC\u00ae, a Standardized Extract of Cultured. J. Immunol. Res. 2019;2019:3758576. doi: 10.1155/2019/3758576.", "ArticleIdList": ["10.1155/2019/3758576", "PMC6942843", "31930148"]}, {"Citation": "Spierings E.L., Fujii H., Sun B., Walshe T. A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. J. Nutr. Sci. Vitaminol. 2007;53:536\u2013539. doi: 10.3177/jnsv.53.536.", "ArticleIdList": ["10.3177/jnsv.53.536", "18202543"]}, {"Citation": "Cao Z., Chen X., Lan L., Zhang Z., Du J., Liao L. Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice. Nutr. Res. Pract. 2015;9:129\u2013136. doi: 10.4162/nrp.2015.9.2.129.", "ArticleIdList": ["10.4162/nrp.2015.9.2.129", "PMC4388943", "25861418"]}, {"Citation": "Pan J., Yang C., Jiang Z., Huang J. Murr: A traditional Chinese medicine with potent anti-tumor effects. Cancer Manag. Res. 2019;11:1541\u20131549. doi: 10.2147/CMAR.S193174.", "ArticleIdList": ["10.2147/CMAR.S193174", "PMC6389013", "30863164"]}, {"Citation": "Zhang T., Wang K., Zhang J., Wang X., Chen Z., Ni C., Qiu F., Huang J. Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt/\u03b2-catenin pathway. Oncol. Lett. 2013;5:1171\u20131176. doi: 10.3892/ol.2013.1145.", "ArticleIdList": ["10.3892/ol.2013.1145", "PMC3629070", "23599758"]}, {"Citation": "Hu Z., Yang A., Su G., Zhao Y., Wang Y., Chai X., Tu P. Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV. Sci. Rep. 2016;6:31298. doi: 10.1038/srep31298.", "ArticleIdList": ["10.1038/srep31298", "PMC4977525", "27503760"]}, {"Citation": "Qi W., Sun M., Kong X., Li Y., Wang X., Lv S., Ding X., Gao S., Cun J., Cai C., et al. Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells. Oncotarget. 2016;7:26003\u201326015. doi: 10.18632/oncotarget.8303.", "ArticleIdList": ["10.18632/oncotarget.8303", "PMC5041960", "27027343"]}, {"Citation": "Shan L., Li Y., Jiang H., Tao Y., Qian Z., Li L., Cai F., Ma L., Yu Y. Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1. J. Cancer. 2017;8:4087\u20134097. doi: 10.7150/jca.21018.", "ArticleIdList": ["10.7150/jca.21018", "PMC5706012", "29187885"]}, {"Citation": "Chen Q., Shu C., Laurence A.D., Chen Y., Peng B.G., Zhen Z.J., Cai J.Q., Ding Y.T., Li L.Q., Zhang Y.B., et al. Effect of Huaier granule on recurrence after curative resection of HCC: A multicentre, randomised clinical trial. Gut. 2018;67:2006\u20132016. doi: 10.1136/gutjnl-2018-315983.", "ArticleIdList": ["10.1136/gutjnl-2018-315983", "29802174"]}, {"Citation": "Myint P.P., Dao T.T.P., Kim Y.S. Anticancer Activity of. Molecules. 2019;24:54. doi: 10.3390/molecules24173054.", "ArticleIdList": ["10.3390/molecules24173054", "PMC6749242", "31443460"]}, {"Citation": "Pham H.H., Seong Y.A., Oh C.W., Kim G.D. The herbal medicine Cyperus amuricus inhibits proliferation of human hepatocellular carcinoma Hep3B cells by inducing apoptosis and arrest at the G0/G1 cell cycle phase. Int. J. Oncol. 2016;49:2046\u20132054. doi: 10.3892/ijo.2016.3698.", "ArticleIdList": ["10.3892/ijo.2016.3698", "27667556"]}, {"Citation": "Lee R.T., Yang P., Alahmadi A., McQuade J., Yuan E., Difeo A., Narla G., Kaseb A. Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series. Case Rep. Oncol. 2021;14:224\u2013231. doi: 10.1159/000511566.", "ArticleIdList": ["10.1159/000511566", "PMC7983630", "33776708"]}, {"Citation": "Galle P.R., Foerster F., Kudo M., Chan S.L., Llovet J.M., Qin S., Schelman W.R., Chintharlapalli S., Abada P.B., Sherman M., et al. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver Int. 2019;39:2214\u20132229. doi: 10.1111/liv.14223.", "ArticleIdList": ["10.1111/liv.14223", "31436873"]}, {"Citation": "Ohnishi H., Asamoto M., Tujimura K., Hokaiwado N., Takahashi S., Ogawa K., Kuribayashi M., Ogiso T., Okuyama H., Shirai T. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci. 2004;95:936\u2013942. doi: 10.1111/j.1349-7006.2004.tb03180.x.", "ArticleIdList": ["10.1111/j.1349-7006.2004.tb03180.x", "15596041"]}, {"Citation": "Yaku K., Matsui-Yuasa I., Azuma H., Kojima-Yuasa A. 1\u2019-Acetoxychavicol acetate enhances the phase II enzyme activities via the increase in intranuclear Nrf2 level and cytosolic p21 level. Am. J. Chin. Med. 2011;39:789\u2013802. doi: 10.1142/S0192415X11009196.", "ArticleIdList": ["10.1142/S0192415X11009196", "21721157"]}, {"Citation": "Wu J.T., Archer S.Y., Hinnebusch B., Meng S., Hodin R.A. Transient vs. prolonged histone hyperacetylation: Effects on colon cancer cell growth, differentiation, and apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001;280:G482\u2013G490. doi: 10.1152/ajpgi.2001.280.3.G482.", "ArticleIdList": ["10.1152/ajpgi.2001.280.3.G482", "11171632"]}, {"Citation": "Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer. 1993;55:498\u2013505. doi: 10.1002/ijc.2910550329.", "ArticleIdList": ["10.1002/ijc.2910550329", "8397167"]}, {"Citation": "Gleave M.E., Sato N., Sadar M., Yago V., Bruchovsky N., Sullivan L. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model. J. Cell Biochem. 1998;69:271\u2013281. doi: 10.1002/(SICI)1097-4644(19980601)69:3<271::AID-JCB5>3.0.CO;2-O.", "ArticleIdList": ["10.1002/(SICI)1097-4644(19980601)69:3<271::AID-JCB5>3.0.CO;2-O", "9581866"]}, {"Citation": "Yamamoto H., Fujimoto J., Okamoto E., Furuyama J., Tamaoki T., Hashimoto-Tamaoki T. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. Int. J. Cancer. 1998;76:897\u2013902. doi: 10.1002/(SICI)1097-0215(19980610)76:6<897::AID-IJC21>3.0.CO;2-Z.", "ArticleIdList": ["10.1002/(SICI)1097-0215(19980610)76:6<897::AID-IJC21>3.0.CO;2-Z", "9626359"]}, {"Citation": "Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell G.A., Beecher C.W., Fong H.H., Kinghorn A.D., Brown D.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1995;1:1046\u20131051. doi: 10.1038/nm1095-1046.", "ArticleIdList": ["10.1038/nm1095-1046", "7489361"]}, {"Citation": "Fulda S., Jeremias I., Pietsch T., Debatin K.M. Betulinic acid: A new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin Padiatr. 1999;211:319\u2013322. doi: 10.1055/s-2008-1043808.", "ArticleIdList": ["10.1055/s-2008-1043808", "10472570"]}, {"Citation": "Zuco V., Supino R., Righetti S.C., Cleris L., Marchesi E., Gambacorti-Passerini C., Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002;175:17\u201325. doi: 10.1016/S0304-3835(01)00718-2.", "ArticleIdList": ["10.1016/S0304-3835(01)00718-2", "11734332"]}, {"Citation": "Tatsuka M., Maeda M., Ota T. Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2) Jpn. J. Cancer Res. 2001;92:1184\u20131189. doi: 10.1111/j.1349-7006.2001.tb02138.x.", "ArticleIdList": ["10.1111/j.1349-7006.2001.tb02138.x", "PMC5926664", "11714442"]}, {"Citation": "Nakata H., Kikuchi Y., Tode T., Hirata J., Kita T., Ishii K., Kudoh K., Nagata I., Shinomiya N. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res. 1998;89:733\u2013740. doi: 10.1111/j.1349-7006.1998.tb03278.x.", "ArticleIdList": ["10.1111/j.1349-7006.1998.tb03278.x", "PMC5921889", "9738980"]}, {"Citation": "Odashima S., Ohta T., Kohno H., Matsuda T., Kitagawa I., Abe H., Arichi S. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res. 1985;45:2781\u20132784.", "ArticleIdList": ["3986809"]}, {"Citation": "Zhu J.H., Takeshita T., Kitagawa I., Morimoto K. Suppression of the formation of sister chromatid exchanges by low concentrations of ginsenoside Rh2 in human blood lymphocytes. Cancer Res. 1995;55:1221\u20131223.", "ArticleIdList": ["7882311"]}, {"Citation": "Song Y., Sun B., Hao L., Hu J., Du S., Zhou X., Zhang L., Liu L., Gong L., Chi X., et al. Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma. Oncotarget. 2016;7:58470\u201358482. doi: 10.18632/oncotarget.11298.", "ArticleIdList": ["10.18632/oncotarget.11298", "PMC5295444", "27542262"]}, {"Citation": "Liu X., Li M., Wang X., Dang Z., Yu L., Jiang Y., Yang Z. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine. 2019;62:152930. doi: 10.1016/j.phymed.2019.152930.", "ArticleIdList": ["10.1016/j.phymed.2019.152930", "31128485"]}, {"Citation": "Liu Y., Li Y., Wang X., Huang Y., Zhang Q., Shi K., Ran C., Hou J. Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3-4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment. J. Altern. Complement. Med. 2020;26:956\u2013965. doi: 10.1089/acm.2019.0334.", "ArticleIdList": ["10.1089/acm.2019.0334", "32614605"]}, {"Citation": "Tsai T.Y., Livneh H., Hung T.H., Lin I.H., Lu M.C., Yeh C.C. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide population-based cohort study. BMJ Open. 2017;7:e014571. doi: 10.1136/bmjopen-2016-014571.", "ArticleIdList": ["10.1136/bmjopen-2016-014571", "PMC5278254", "28122837"]}, {"Citation": "Tsai F.J., Cheng C.F., Chen C.J., Lin C.Y., Wu Y.F., Li T.M., Chuang P.H., Wu Y.C., Lai C.H., Liu X., et al. Effects of Chinese herbal medicine therapy on survival and hepatic outcomes in patients with hepatitis C virus infection in Taiwan. Phytomedicine. 2019;57:30\u201338. doi: 10.1016/j.phymed.2018.09.237.", "ArticleIdList": ["10.1016/j.phymed.2018.09.237", "30668320"]}, {"Citation": "Qi F., Zhao L., Zhou A., Zhang B., Li A., Wang Z., Han J. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci. Trends. 2015;9:16\u201334. doi: 10.5582/bst.2015.01019.", "ArticleIdList": ["10.5582/bst.2015.01019", "25787906"]}, {"Citation": "Jingjing H., Hongna H., Xiaojiao W., Yan G., Yuexue Z., Yueqiang H. Bie Jia Jian pill enhances the amelioration of bone mesenchymal stem cells on hepatocellular carcinoma progression. J. Nat. Med. 2021 doi: 10.1007/s11418-021-01548-4.", "ArticleIdList": ["10.1007/s11418-021-01548-4", "PMC8732910", "34297271"]}, {"Citation": "Huang Y., Zhou C., Wen H., Chen Y., Xie Y., Lan X., Lin J., Huang X., Mo Y., Yang C., et al. Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the. Integr. Cancer Ther. 2020;19:1534735419900804. doi: 10.1177/1534735419900804.", "ArticleIdList": ["10.1177/1534735419900804", "PMC7016307", "32046536"]}, {"Citation": "Maru G.B., Hudlikar R.R., Kumar G., Gandhi K., Mahimkar M.B. Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials. World J. Biol. Chem. 2016;7:88\u201399. doi: 10.4331/wjbc.v7.i1.88.", "ArticleIdList": ["10.4331/wjbc.v7.i1.88", "PMC4768127", "26981198"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "16"}, {"Year": "2021", "Month": "11", "Day": "10"}, {"Year": "2021", "Month": "11", "Day": "15"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "1", "Minute": "13"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "11", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["34830907", "PMC8616323", "10.3390/cancers13225753", "cancers13225753"]}}], "PubmedBookArticle": []}